Main Article Content

Abstract

The quality of pharmaceuticals has been a concern of the World Health Organization (WHO) since its inception. This includes the quality of starting materials, including active substances and excipients, for the production of medicinal products and here packaging materials are also covered. Any risks that may emanate from starting materials of inappropriate quality must be avoided for the benefit and safety of patients using medicinal products. Drug products are complex mixtures of drug and excipients, and as such, their chemical and physical stability kinetics are complex. A thorough knowledge of the chemical and physical stability of drugs and dosage forms is critical in the development and evaluation of pharmaceuticals. Each ingredient, whether therapeutically active or pharmaceutically necessary, can affect the stability of drug substances and dosage forms.It is most important to ensure that a particular formulation when packaged in a specific container will remain within its physical, chemical, microbiological, therapeutic and toxicological specifications on storage for a specified time period. In order to have such an assurance we need to conduct a rigorous stability testing program on the product in the form that is finally to be marketed. This paper presents a reasonably systematic and comprehensive approach to the subject of chemical and physical drug stability and the factors affecting drug stability.


 

Keywords

Shelf-Life of Drugs Stability Studies Drug Instability Factors Affecting

Article Details

How to Cite
Dr. Ameena Yasmeen, Dr. Ghulamuddin Sofi, & Dr. Kaleemullah khan. (2021). Factors Affecting Drug Stability-A Major Concern to the Pharmaceutical Industry in the Drug Development and its Commercialization. International Journal of Research in Pharmacology & Pharmacotherapeutics, 10(3), 205-218. Retrieved from https://ijrpp.com/ijrpp/article/view/392

References

  1. [1]. Barnes A.R Product Stability and Stability Testing Chapter-44 Aulton’s Pharmaceutics 3rd Edition, Edited by Michael E Aulton Elsevier; 2007 :650-70.
  2. [2]. Waterman KC understanding and predicting pharmaceutical product shelf-life chapter-6 Handbook of Stability Testing in Pharmaceutical Development 2009 Edited By: Huynh-Ba K Springer (India) Private Limited, 3rd Floor, GandharvaMahavidyalaya, Deendayal Upadhyaya Marg, New Delhi, India. P:117-21.
  3. [3]. Guo Y an overview of physical stability of pharmaceuticals chapter-19 Pharmaceutical Stability Testing to Support Global Markets 2010 Edited by: Huynh-Ba K Springer P:145.
  4. [4]. Anonymous United States Pharmacopeia Chapter-26 and National Formulary 21st Edition, 2003.
  5. [5]. Carstensen, J. T. and Rhodes, C. T., Drug Stability: Principles and Practices, 3rd ed., Marcel Dekker, Inc., New York, 2000.
  6. [6]. O’Donnell PB, BoskerAD Stability of Pharmaceutical Products. Chapter-52 Remington- The Science and Practice of Pharmacy Vol-1 21st Edition 2006 Williams L & Wilkins. Published by Wolters Kluwer (India) Pvt Ltd., New Delhi. P 1025-1036.
  7. [7]. Anonymous. The United States Pharmacopeia, the National Formulary. Asian Edition. 2004; by Authority of The United States Pharmacopeial Convention, Inc. 12601 Twin brook Parkway, Rockville, MD 20852. P1191, 2605-2608.
  8. [8]. Yoshioka S and Stella V J. Stability of Drugs and Dosage Forms. 2000. 2nd Indian Reprint-2009. Published by Springer (India) Private Limited, Akash Deep Building, Barakhamba Road, New Delhi-110001, India. P:3-5.
  9. [9]. Baertschi SW, Jansen PJ Stress Testing: A Predictive Tool Pharmaceutical Stress Testing- Predicting Drug Degradation First Indian Reprint 2008 Published by Taylor & Francis Group Boca Raton Singapore. Page: 23.
  10. [10]. Florence AT, and Siepmann J. Modern Pharmaceutics, Basic Principles and Systems. 5th Edition. 2009; Vol-1: P203-372. Published by Informa Health Care USA, Inc, 52 Vanderbilt Avenue. New York, NY 10017.
  11. [11]. Jamali F, Mehvar R, Pasutto Fm. Enantioselective aspects of drug action and disposition: therapeutic pitfalls. J Pharm Sci 1989; 78:695-715.
  12. [12]. Baertschi SW, Alsante K M Stress Testing: The chemistry of drug degradation chapter-3 in Pharmaceutical Stress Testing- Predicting Drug Degradation First Indian Reprint 2008 Published by Taylor & Francis Group Boca Raton Singapore. Page:109-115.
  13. [13]. Tonnesen HH. Photodecomposition of Drugs. In: Swarbrick J, Ed. Encyclopedia of Pharmaceutical Technology. 3rd Ed. New York: Informa Healthcare, 2006:2859-2865.
  14. [14]. Fasani E and Albini A. Photostability stress testing chapter-10 in Pharmaceutical Stability Testing to Support Global Markets 2010 Edited by: Huynh-Ba K Springer P:318.
  15. [15]. Pharmaceutical and Formulation Considerations- Chapter-4 In Ansel’s Pharmaceutical Dosage Forms and Drug Delivery Systems 10th Edition, P:135.
  16. [16]. Naveed S, Basheer S, Qamar F (2016) Stability of a Dosage Form and Forced Degradation Studies. J BioequivAvailab 8: 191-193. doi:10.4172/ jbb.1000292.